Question

In: Biology

Suppose everyone had access to free CRISPR/CAS9 based gene editing to correct mutations at embryonic level....

Suppose everyone had access to free CRISPR/CAS9 based gene editing to correct mutations at embryonic level. Now answer briefly the following questions

1) Is it true or false that you might not need an artificial repair template to correct the mutation? Explain the reason for your answer (no more than 1 brief sentence).

2) What could still be an ethical concern with gene editing on embryo? Limit your answer to 1 concern.

Solutions

Expert Solution

Ans: CRISPR/Cas9 based gene editing tool has 3 components mainly, guide RNA which is the RNA that is complementary to the gene which needs to be modified, Cas9 is the enzyme that cuts the gene in the DNA at the site guided by the guide RNA and a template DNA for repairing.

The template DNA for repairing is sometimes optional depending how the editing needs to be done. If we dont want to insert any extra base or delete a base, then a repair template is provided.

Similarly to correct a mutation in the embryo, we need to provide the template which contains the sequence that corrects the mutation that the repair enzymes will use it to insert and remove the mutated fragment.

Hence, it is false that we might need not require an artificial repair template. Artificial template must be provided so that any other base should not be added or deleted.

Hope this will help you.


Related Solutions

When biologists use the CRISPR-Cas9 gene editing system, they rely on one of two types of...
When biologists use the CRISPR-Cas9 gene editing system, they rely on one of two types of gene repair to occur: non-homologous end joining (NEHJ) or homology directed repair (HDR). Explain the difference between these two types of repair, and why HDR in the presence of a “repair template” - desired sequence of external DNA, has the potential to allow for more precise gene editing.
gene editing a. How does the enzyme used in CRISPR-Cas9 differ from enzymes used in recombinant...
gene editing a. How does the enzyme used in CRISPR-Cas9 differ from enzymes used in recombinant DNA technology? b.Can you predict a potential risk of somatic cell gene editing?
what are 8 pro facts and 8 con facts about gene editing and CRISPR-Cas9. Moreover, would...
what are 8 pro facts and 8 con facts about gene editing and CRISPR-Cas9. Moreover, would you agree that CRISPR-Cas9 gene editing in human embryos would have a positive outcome?
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT